DLA
MDLN icon

Douglas Lane & Associates’s Medline Inc MDLN Stock Holding History

Douglas Lane & Associates’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.2M Buy
554,224
+499,459
+912% +$18.3M 0.26% 105
2026
Q2 		$2.16M Buy
+54,765
New +$2.21M 0.03% 150

Other funds holding MDLN

CAM
Clio Asset Management Charlottesville, Virginia $119M AUM 1.1% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
TA
TrueWealth Advisors Birmingham, Alabama $445M AUM 13.38% 1-Year Est. Return
MCM
Mengis Capital Management Portland, Oregon $673M AUM 34.75% 1-Year Est. Return
FA
Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return
SWM
Sendero Wealth Management San Antonio, Texas $1B AUM 21.35% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Douglas Lane & Associates's MDLN Position: Q3 2026 in Review

Douglas Lane & Associates increased its Medline Inc (MDLN) stake by 912% in Q3 2026, buying an estimated $18.3M and bringing the position to 554,224 shares worth $19.2M. The position accounts for 0.26% of the portfolio, ranked #105.

Douglas Lane & Associates first reported a position in MDLN in Q2 2026 and has held it in 2 quarters since. 18 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Douglas Lane & Associates held 554,224 shares of Medline Inc worth $19.2M as of Q3 2026.
  • Douglas Lane & Associates bought 499,459 Medline Inc shares in Q3 2026, an estimated $18.3M.
  • Medline Inc made up 0.26% of Douglas Lane & Associates's portfolio in Q3 2026, its #105 holding.
  • Douglas Lane & Associates first reported a position in Medline Inc in Q2 2026 and has held it in 2 quarters since.
  • 18 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Douglas Lane & Associates's 13F filing for Q3 2026, filed 9 Oct 2026.